-
Auburn Community Hospital to build $14M radiation treatment center
Auburn (N.Y.) Community Hospital was approved by the state to build a $14 million radiation treatment center, syracuse.com reported July 14. -
Children's Hospital Los Angeles part of clinical trials for neuroblastoma radiation therapy
Children's Hospital Los Angeles has begun offering a radiation drug therapy using metaiodobenzylguanidine, or MIGB, to children with high-risk neuroblastoma. -
6 recent cancer partnerships
Six recent oncology-related partnerships formed, advanced or renewed Becker's has covered since June 22: -
Cancer Center at Illinois develops groundbreaking imaging technology
Urbana, Ill.-based Cancer Center at Illinois recently developed a groundbreaking cancer imaging technology by recreating the mantis shrimp's visual system in a single device to provide physicians with clearer images for disease detection, WCIA reported July 12. -
Ludwig Cancer Research Institute appoints Dr. Pat Morin deputy scientific director
New York City-based Ludwig Cancer Research Institute named Pat Morin, PhD, its new deputy scientific director July 12. -
Cancer-causing herbicide found in 80% of US urine samples
Glyphosate, a cancer-causing herbicide, was found in 80 percent of urine samples from kids and adults in the U.S., the CDC's "National Health and Nutrition Examination Survey" found. -
Amazon, Fred Hutchinson launch cancer vaccine clinical trial
Amazon launched an FDA-approved clinical trial for its cancer vaccines. -
Lung Cancer Research Foundation establishes scientific committee
The Lung Cancer Research Foundation established a scientific executive committee July 11 to create a strategic roadmap to guide the foundation's research investment and identify areas of unmet need. -
Dr. Dhanpat Jain appointed to Cancer Committee of College of American Pathologists
Dhanpat Jain, MD, professor of pathology and of medicine in the field of digestive diseases at New Haven, Conn.-based Yale School of Medicine, recently was appointed to the Cancer Committee of the College of American Pathologists. -
Yale Cancer Center names Dr. Kiran Turaga chief of surgical oncology
New Haven, Conn.-based Yale Cancer Center appointed Kiran Turaga, MD, division chief of surgical oncology July 6. His appointment is effective Oct. 1. -
Top 10 oncology stories of June
Here are the top 10 oncology stories Becker's covered in June: -
Christ Hospital joins Dana-Farber collaborative
Cincinnati-based Christ Hospital Health Network is joining the Dana-Farber Brigham Cancer Care Collaborative, WXVU reported July 5. -
Moffitt, Turnstone Biologics ink strategic alliance
Tampa, Fla.-based Moffitt Cancer Center entered a strategic alliance July 6 with Turnstone Biologics, a biotechnology company developing immunotherapies to treat and cure solid tumors. -
McLaren Proton Therapy Center set to be 1st to offer upright beam Leo treatment
Flint, Mich.-based McLaren Proton Therapy Center is set to become the first in the world to offer patients proton therapy with Leo Cancer Care's upright treatment technology, it said in an email to Becker's on July 5. -
Cleveland Clinic performs 1st-in-world multi-organ transplant for appendix cancer
Cleveland Clinic performed the first-in-the-world full multi-organ transplant in September to treat a patient with pseudomyxoma peritonei, a rare form of appendix cancer. -
HonorHealth researchers' new therapy changes NCCN guidelines for pancreatic cancer
Scottsdale, Ariz.-based HonorHealth researchers developed a novel drug combination therapy for pancreatic cancer patients that has become part of the new National Comprehensive Cancer Network guidelines for the disease, the system shared with Becker's. -
5 recent cancer center donations
Here are five recent cancer center donations Becker's has covered since April 20: -
The cancer moonshot: Here's how we get there
A generation ago we spoke of cancer in hushed tones. We whispered about the suspected "Big C," diagnoses were kept secret, and that was that. -
Dana-Farber Cancer Institute, Brigham and Women's Hospital designated as rare disease clinical center
Boston-based Dana-Farber Cancer Institute and Brigham and Women's Hospital were designated as a Pheo Para Clinical Center June 28 for patients with rare neuroendocrine tumors. -
$5.3M grant funds Washington University School of Medicine lung cancer recurrence research
St. Louis-based Washington University School of Medicine received a $5.3 million grant June 28 from the National Cancer Institute of the National Institutes of Health for lung cancer recurrence research efforts.
Page 37 of 50